FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 214.24 Million USD | 6.81% |
| 2023 | 200.58 Million USD | 0.62% |
| 2022 | 199.34 Million USD | 5.19% |
| 2021 | 189.5 Million USD | 5.13% |
| 2020 | 180.25 Million USD | 34.96% |
| 2019 | 133.56 Million USD | 12.89% |
| 2018 | 118.31 Million USD | 19.79% |
| 2017 | 98.76 Million USD | 16.35% |
| 2016 | 84.88 Million USD | 10.98% |
| 2015 | 76.49 Million USD | -0.39% |
| 2014 | 76.78 Million USD | 4.97% |
| 2013 | 73.15 Million USD | 117.61% |
| 2012 | 33.61 Million USD | 6.44% |
| 2011 | 31.58 Million USD | 46.01% |
| 2010 | 21.62 Million USD | -23.73% |
| 2009 | 28.35 Million USD | -19.49% |
| 2008 | 35.22 Million USD | -14.52% |
| 2007 | 41.21 Million USD | -27.99% |
| 2006 | 57.22 Million USD | -24.79% |
| 2005 | 76.09 Million USD | -1.43% |
| 2004 | 77.2 Million USD | 31.41% |
| 2003 | 58.74 Million USD | -19.33% |
| 2002 | 72.82 Million USD | -14.47% |
| 2001 | 85.15 Million USD | 0.66% |
| 2000 | 84.59 Million USD | -13.32% |
| 1999 | 97.6 Million USD | -9.96% |
| 1998 | 108.4 Million USD | 1.59% |
| 1997 | 106.7 Million USD | 69.1% |
| 1996 | 63.1 Million USD | 14.94% |
| 1995 | 54.9 Million USD | 13.43% |
| 1994 | 48.4 Million USD | 13.08% |
| 1993 | 42.8 Million USD | 5.94% |
| 1992 | 40.4 Million USD | 0.25% |
| 1991 | 40.3 Million USD | -3.13% |
| 1990 | 41.6 Million USD | -9.96% |
| 1989 | 46.2 Million USD | 5.24% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 209.63 Million USD | 3.64% |
| 2024 Q2 | 202.26 Million USD | 0.35% |
| 2024 Q1 | 201.55 Million USD | 0.49% |
| 2024 Q4 | 214.24 Million USD | 2.2% |
| 2023 Q4 | 200.58 Million USD | 0.63% |
| 2023 FY | 200.58 Million USD | 0.62% |
| 2023 Q1 | 198.02 Million USD | -0.66% |
| 2023 Q2 | 197.49 Million USD | -0.26% |
| 2023 Q3 | 199.33 Million USD | 0.93% |
| 2022 Q4 | 199.34 Million USD | 1.89% |
| 2022 Q1 | 188.22 Million USD | -0.67% |
| 2022 Q2 | 193.73 Million USD | 2.92% |
| 2022 Q3 | 195.64 Million USD | 0.99% |
| 2022 FY | 199.34 Million USD | 5.19% |
| 2021 Q4 | 189.5 Million USD | 2.3% |
| 2021 Q3 | 185.25 Million USD | 1.7% |
| 2021 Q2 | 182.14 Million USD | 0.49% |
| 2021 Q1 | 181.25 Million USD | 0.55% |
| 2021 FY | 189.5 Million USD | 5.13% |
| 2020 Q2 | 171.67 Million USD | 2.87% |
| 2020 Q3 | 171.18 Million USD | -0.29% |
| 2020 Q4 | 180.25 Million USD | 5.3% |
| 2020 Q1 | 166.88 Million USD | 24.95% |
| 2020 FY | 180.25 Million USD | 34.96% |
| 2019 Q4 | 133.56 Million USD | 5.5% |
| 2019 FY | 133.56 Million USD | 12.89% |
| 2019 Q1 | 120.24 Million USD | 1.63% |
| 2019 Q2 | 122.86 Million USD | 2.18% |
| 2019 Q3 | 126.59 Million USD | 3.03% |
| 2018 Q1 | 101.22 Million USD | 2.49% |
| 2018 Q4 | 118.31 Million USD | 11.09% |
| 2018 Q3 | 106.5 Million USD | 1.25% |
| 2018 Q2 | 105.18 Million USD | 3.91% |
| 2018 FY | 118.31 Million USD | 19.79% |
| 2017 Q1 | 86.14 Million USD | 1.48% |
| 2017 Q2 | 88.28 Million USD | 2.49% |
| 2017 FY | 98.76 Million USD | 16.35% |
| 2017 Q4 | 98.76 Million USD | 7.56% |
| 2017 Q3 | 91.82 Million USD | 4.01% |
| 2016 FY | 84.88 Million USD | 10.98% |
| 2016 Q1 | 79.02 Million USD | 3.31% |
| 2016 Q4 | 84.88 Million USD | 3.51% |
| 2016 Q2 | 80.42 Million USD | 1.77% |
| 2016 Q3 | 82.01 Million USD | 1.98% |
| 2015 FY | 76.49 Million USD | -0.39% |
| 2015 Q2 | 79.04 Million USD | 0.35% |
| 2015 Q3 | 74.54 Million USD | -5.69% |
| 2015 Q1 | 78.76 Million USD | 2.57% |
| 2015 Q4 | 76.49 Million USD | 2.62% |
| 2014 FY | 76.78 Million USD | 4.97% |
| 2014 Q4 | 76.78 Million USD | 0.84% |
| 2014 Q2 | 77.08 Million USD | 1.97% |
| 2014 Q1 | 75.59 Million USD | 3.35% |
| 2014 Q3 | 76.14 Million USD | -1.22% |
| 2013 Q2 | 36.8 Million USD | 3.79% |
| 2013 Q3 | 73.28 Million USD | 99.11% |
| 2013 Q4 | 73.15 Million USD | -0.18% |
| 2013 FY | 73.15 Million USD | 117.61% |
| 2013 Q1 | 35.46 Million USD | 5.49% |
| 2012 Q1 | 33.1 Million USD | 4.82% |
| 2012 Q2 | 33.45 Million USD | 1.06% |
| 2012 Q3 | 34.82 Million USD | 4.1% |
| 2012 Q4 | 33.61 Million USD | -3.48% |
| 2012 FY | 33.61 Million USD | 6.44% |
| 2011 FY | 31.58 Million USD | 46.01% |
| 2011 Q4 | 31.58 Million USD | 19.83% |
| 2011 Q3 | 26.35 Million USD | 9.47% |
| 2011 Q2 | 24.07 Million USD | 9.49% |
| 2011 Q1 | 21.98 Million USD | 1.66% |
| 2010 Q4 | 21.62 Million USD | -6.88% |
| 2010 Q3 | 23.22 Million USD | -6.72% |
| 2010 Q2 | 24.9 Million USD | -9.3% |
| 2010 Q1 | 27.45 Million USD | -3.2% |
| 2010 FY | 21.62 Million USD | -23.73% |
| 2009 Q1 | 33.39 Million USD | -5.19% |
| 2009 Q4 | 28.35 Million USD | -4.3% |
| 2009 FY | 28.35 Million USD | -19.49% |
| 2009 Q2 | 32.93 Million USD | -1.4% |
| 2009 Q3 | 29.63 Million USD | -10.01% |
| 2008 Q2 | 41.22 Million USD | -2.26% |
| 2008 Q1 | 42.17 Million USD | 2.35% |
| 2008 Q3 | 40.96 Million USD | -0.64% |
| 2008 Q4 | 35.22 Million USD | -14.01% |
| 2008 FY | 35.22 Million USD | -14.52% |
| 2007 Q3 | 48.47 Million USD | -8.89% |
| 2007 Q2 | 53.2 Million USD | -1.42% |
| 2007 Q1 | 53.97 Million USD | -5.69% |
| 2007 Q4 | 41.21 Million USD | -14.99% |
| 2007 FY | 41.21 Million USD | -27.99% |
| 2006 Q3 | 61.71 Million USD | -10.89% |
| 2006 Q4 | 57.22 Million USD | -7.27% |
| 2006 FY | 57.22 Million USD | -24.79% |
| 2006 Q1 | 69.8 Million USD | -8.27% |
| 2006 Q2 | 69.25 Million USD | -0.78% |
| 2005 Q3 | 75.2 Million USD | -6.02% |
| 2005 FY | 76.09 Million USD | -1.43% |
| 2005 Q4 | 76.09 Million USD | 1.19% |
| 2005 Q2 | 80.01 Million USD | 1.73% |
| 2005 Q1 | 78.65 Million USD | 1.88% |
| 2004 Q4 | 77.2 Million USD | 3.83% |
| 2004 FY | 77.2 Million USD | 31.41% |
| 2004 Q1 | 60.57 Million USD | 3.11% |
| 2004 Q2 | 65.09 Million USD | 7.46% |
| 2004 Q3 | 74.35 Million USD | 14.22% |
| 2003 FY | 58.74 Million USD | -19.33% |
| 2003 Q4 | 58.74 Million USD | -10.36% |
| 2003 Q1 | 71.48 Million USD | -1.85% |
| 2003 Q2 | 67.64 Million USD | -5.38% |
| 2003 Q3 | 65.53 Million USD | -3.11% |
| 2002 Q1 | 79.45 Million USD | -6.7% |
| 2002 Q2 | 76.52 Million USD | -3.69% |
| 2002 Q4 | 72.82 Million USD | -3.07% |
| 2002 Q3 | 75.13 Million USD | -1.81% |
| 2002 FY | 72.82 Million USD | -14.47% |
| 2001 Q3 | 82.17 Million USD | -6.74% |
| 2001 Q4 | 85.15 Million USD | 3.62% |
| 2001 FY | 85.15 Million USD | 0.66% |
| 2001 Q2 | 88.12 Million USD | -4.0% |
| 2001 Q1 | 91.79 Million USD | 8.5% |
| 2000 FY | 84.59 Million USD | -13.32% |
| 2000 Q4 | 84.59 Million USD | 0.33% |
| 2000 Q3 | 84.32 Million USD | -4.29% |
| 2000 Q2 | 88.1 Million USD | -4.86% |
| 2000 Q1 | 92.6 Million USD | -5.12% |
| 1999 Q3 | 102.3 Million USD | -4.66% |
| 1999 Q1 | 110.9 Million USD | 2.31% |
| 1999 FY | 97.6 Million USD | -9.96% |
| 1999 Q4 | 97.6 Million USD | -4.59% |
| 1999 Q2 | 107.3 Million USD | -3.25% |
| 1998 Q4 | 108.4 Million USD | 3.34% |
| 1998 FY | 108.4 Million USD | 1.59% |
| 1998 Q1 | 104.9 Million USD | -1.69% |
| 1998 Q2 | 101.4 Million USD | -3.34% |
| 1998 Q3 | 104.9 Million USD | 3.45% |
| 1997 Q2 | 71 Million USD | 12.88% |
| 1997 Q4 | 106.7 Million USD | 52.65% |
| 1997 Q1 | 62.9 Million USD | -0.32% |
| 1997 Q3 | 69.9 Million USD | -1.55% |
| 1997 FY | 106.7 Million USD | 69.1% |
| 1996 Q1 | 56.2 Million USD | 2.37% |
| 1996 FY | 63.1 Million USD | 14.94% |
| 1996 Q4 | 63.1 Million USD | -0.16% |
| 1996 Q3 | 63.2 Million USD | 9.15% |
| 1996 Q2 | 57.9 Million USD | 3.02% |
| 1995 Q2 | 50.3 Million USD | 1.21% |
| 1995 Q1 | 49.7 Million USD | 2.69% |
| 1995 Q3 | 52.2 Million USD | 3.78% |
| 1995 Q4 | 54.9 Million USD | 5.17% |
| 1995 FY | 54.9 Million USD | 13.43% |
| 1994 Q4 | 48.4 Million USD | 1.26% |
| 1994 FY | 48.4 Million USD | 13.08% |
| 1994 Q3 | 47.8 Million USD | 9.89% |
| 1994 Q1 | 43.1 Million USD | 0.7% |
| 1994 Q2 | 43.5 Million USD | 0.93% |
| 1993 Q1 | 39.5 Million USD | -2.23% |
| 1993 Q2 | 40.4 Million USD | 2.28% |
| 1993 Q3 | 42.2 Million USD | 4.46% |
| 1993 Q4 | 42.8 Million USD | 1.42% |
| 1993 FY | 42.8 Million USD | 5.94% |
| 1992 Q3 | 39.7 Million USD | 2.85% |
| 1992 FY | 40.4 Million USD | 0.25% |
| 1992 Q1 | 39.3 Million USD | -2.48% |
| 1992 Q2 | 38.6 Million USD | -1.78% |
| 1992 Q4 | 40.4 Million USD | 1.76% |
| 1991 Q1 | 41.5 Million USD | -0.24% |
| 1991 Q4 | 40.3 Million USD | -2.18% |
| 1991 Q2 | 42.9 Million USD | 3.37% |
| 1991 FY | 40.3 Million USD | -3.13% |
| 1991 Q3 | 41.2 Million USD | -3.96% |
| 1990 Q4 | 41.6 Million USD | 2.46% |
| 1990 Q3 | 40.6 Million USD | -0.98% |
| 1990 FY | 41.6 Million USD | -9.96% |
| 1990 Q2 | 41 Million USD | 0.0% |
| 1989 FY | 46.2 Million USD | 5.24% |
| 1989 Q4 | 46.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -583.052% |
| BrainsWay Ltd. | 62.97 Million USD | -240.224% |
| Cerus Corporation | 197.74 Million USD | -8.343% |
| Envoy Medical, Inc. | 7.64 Million USD | -2704.267% |
| electroCore, Inc. | 16.38 Million USD | -1207.414% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -2685.309% |
| IceCure Medical Ltd | 16.41 Million USD | -1205.582% |
| Inogen, Inc. | 326.19 Million USD | 34.319% |
| OrthoPediatrics Corp. | 449.58 Million USD | 52.346% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -685.647% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1192.272% |
| MaxCyte, Inc. | 268.27 Million USD | 20.139% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2545.889% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5798.979% |
| Orthofix Medical Inc. | 925.31 Million USD | 76.846% |
| PAVmed Inc | 33.11 Million USD | -546.897% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -49.35% |
| RxSight, Inc. | 182.55 Million USD | -17.363% |
| Sight Sciences, Inc. | 166.65 Million USD | -28.56% |
| SI-BONE, Inc. | 230.42 Million USD | 7.021% |
| TELA Bio, Inc. | 78.04 Million USD | -174.505% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 14.95% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1896.701% |
| Acutus Medical, Inc. | 53.96 Million USD | -297.046% |
| Talis Biomedical Corporation | 98.34 Million USD | -117.862% |
| Spectral AI, Inc. | 10.69 Million USD | -1903.797% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 2.013% |
| CVRx, Inc. | 115.22 Million USD | -85.931% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -265.227% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -6777.322% |
| Bioventus Inc. | 810.91 Million USD | 73.58% |
| Venus Concept Inc. | 93.65 Million USD | -128.763% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -732.832% |
| LivaNova PLC | 2.42 Billion USD | 91.182% |
| 908 Devices Inc. | 202.98 Million USD | -5.55% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 73.392% |
| Nemaura Medical Inc. | 14.56 Million USD | -1371.143% |
| NeuroPace, Inc. | 107.65 Million USD | -99.019% |
| LENSAR, Inc. | 69.58 Million USD | -207.891% |
| Apyx Medical Corporation | 79.24 Million USD | -170.376% |
| Cutera, Inc. | 346.29 Million USD | 38.131% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -409.915% |
| BioSig Technologies, Inc. | 1.79 Million USD | -11815.794% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 20.835% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -402.206% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 94.335% |
| Axonics, Inc. | 719.92 Million USD | 70.24% |
| Outset Medical, Inc. | 313.8 Million USD | 31.726% |
| IRIDEX Corporation | 34.43 Million USD | -522.157% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 47.063% |
| IRadimed Corporation | 92.15 Million USD | -132.482% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -3977.769% |
| INVO Bioscience, Inc. | 20.88 Million USD | -925.7% |
| Telesis Bio, Inc. | 70.41 Million USD | -204.279% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -39.028% |
| Varex Imaging Corporation | 1.24 Billion USD | 82.855% |
| Quipt Home Medical Corp. | 247.4 Million USD | 13.404% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2201.246% |
| Pulmonx Corporation | 178.95 Million USD | -19.723% |
| Dynatronics Corporation | 25.94 Million USD | -725.911% |
| Modular Medical, Inc. | 13.8 Million USD | -1451.72% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1897.259% |
| Semler Scientific, Inc. | 78.06 Million USD | -174.446% |
| InMode Ltd. | 863.28 Million USD | 75.183% |
| Bruker Corporation | 4.24 Billion USD | 94.959% |
| Cytosorbents Corporation | 53.26 Million USD | -302.26% |
| DexCom, Inc. | 6.26 Billion USD | 96.58% |
| Align Technology, Inc. | 6.08 Billion USD | 96.478% |
| Viveve Medical, Inc. | 25.91 Million USD | -726.79% |
| ZimVie Inc. | 1.2 Billion USD | 82.225% |
| Movano Inc. | 9.42 Million USD | -2174.132% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 56.95% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5798.979% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -265.227% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 77.511% |
| Profound Medical Corp. | 43.68 Million USD | -390.419% |
| Insulet Corporation | 2.58 Billion USD | 91.722% |
| enVVeno Medical Corporation | 48.63 Million USD | -340.518% |
| Surmodics, Inc. | 185.73 Million USD | -15.352% |
| iCAD, Inc. | 41.41 Million USD | -417.277% |
| Nuwellis, Inc. | 9.77 Million USD | -2092.896% |
| Biotricity, Inc. | 5.94 Million USD | -3505.241% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 50.537% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2498.186% |
| InspireMD, Inc. | 47.64 Million USD | -349.69% |
| PAVmed Inc. | 33.11 Million USD | -546.897% |
| BIOLASE, Inc. | 35.1 Million USD | -510.37% |
| Beyond Air, Inc. | 56.96 Million USD | -276.127% |
| AxoGen, Inc. | 196.82 Million USD | -8.85% |
| Vivani Medical, Inc. | 45.79 Million USD | -367.817% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 23.875% |
| Inari Medical, Inc. | 674.23 Million USD | 68.224% |
| UFP Technologies, Inc. | 404.13 Million USD | 46.987% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -815.637% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -2154.482% |
| Tenon Medical, Inc. | 6.34 Million USD | -3276.611% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -2177.516% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -106.706% |
| AdaptHealth Corp. | 4.61 Billion USD | 95.362% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1294.377% |
| NanoVibronix, Inc. | 6.67 Million USD | -3110.158% |
| Quanterix Corporation | 425.01 Million USD | 49.59% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2201.246% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -298.768% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 87.729% |
| TransMedics Group, Inc. | 706.04 Million USD | 69.656% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -239.04% |
| NeuroMetrix, Inc. | 21.42 Million USD | -900.007% |
| Hyperfine, Inc. | 94.19 Million USD | -127.44% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 20.248% |
| Biomerica, Inc. | 9.25 Million USD | -2215.171% |
| Bone Biologics Corporation | 3.73 Million USD | -5631.93% |
| AVITA Medical, Inc. | 144.33 Million USD | -48.431% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -4300.629% |
| Silk Road Medical, Inc | 265.3 Million USD | 19.247% |